Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Fall Technical MeetingFall Technical Meeting
Not Confirmed
Not Confirmed
05-07 October, 2025
The MedTech ConferenceThe MedTech Conference
Not Confirmed
Not Confirmed
05-08 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Fall Technical MeetingFall Technical Meeting
Industry Trade Show
Not Confirmed
05-07 October, 2025
The MedTech ConferenceThe MedTech Conference
Industry Trade Show
Not Confirmed
05-08 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-bridge-the-gap-between-chemistry-and-performance-to-deliver-precise-optimized-micronization-for-complex-apis
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
22 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/22/3153917/0/en/CRISPR-Therapeutics-and-Sirius-Therapeutics-Announce-First-Patient-Dosed-in-Phase-2-Trial-of-SRSD107-for-Thromboembolic-Disorders-in-Europe.html
19 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/19/3084420/0/en/CRISPR-Therapeutics-and-Sirius-Therapeutics-Announce-Multi-Target-Collaboration-to-Develop-Novel-siRNA-Therapies.html
09 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250507421040/en/Sirius-Therapeutics-Announces-Nearly-%2450-Million-Financing-to-Accelerate-Clinical-Development-of-siRNA-Therapeutics-for-Cardiometabolic-Diseases
10 Dec 2024
// BUSINESSWIRE
02 Dec 2024
// BUSINESSWIRE
ABOUT THIS PAGE